10x Genomics, Inc. Stock Analysis & AI Score
10x Genomics, Inc. (TXG) has an ST Score of 46.9 (C+), driven by its Profitability (A) and held back by its Valuation (D). Analysts rate it Hold with a $53.33 price target (-36.6% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
10x Genomics, Inc. (TXG) has an ST Score of 46.9 (C+), driven by its Profitability (A) and held back by its Valuation (D). Analysts rate it Hold with a $53.33 price target (-36.6% downside).
- Strongest
- ProfitabilityA
- Weakest
- ValuationD
All factor grades
- ProfitabilityA
- MomentumA-
- ForecastC+
- Financial StrengthC-
- GrowthC-
- ValuationD
- Piotroski3/9
Contact
TXG stock: frequently asked questions
What is TXG's ST Score?
10x Genomics, Inc. (TXG) has an ST Score of 46.9 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is TXG a buy, hold, or sell?
Analysts rate TXG a Hold, with a price target of $53.33 (-36.6% vs the current price). Our ST Score grades it C+ (46.9/100). The ST Score is a data-driven signal, not a recommendation.
What are TXG's factor grades?
Valuation D, Profitability A, Financial Strength C-, Momentum A-, Growth C-, Forecast C+.
What is TXG's valuation grade?
10x Genomics, Inc. (TXG) earns a valuation grade of D, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is TXG's growth grade?
10x Genomics, Inc. (TXG) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is TXG's profitability grade?
10x Genomics, Inc. (TXG) earns a profitability grade of A, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is TXG's financial strength grade?
10x Genomics, Inc. (TXG) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for TXG?
The average analyst price target for 10x Genomics, Inc. (TXG) is $53.33 from 22 analysts, which is -36.6% versus the recent price of $84.11.
What is TXG's Piotroski score?
10x Genomics, Inc. (TXG) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.